⚠ Teaching the Market Also Teaches the MarketModerate threat

Intuitive Surgical (ISRG) — threat to the moat

Intuitive proved robotic surgery works, and that proof is now a public good.

Intuitive spent twenty-seven years teaching the surgical profession that robotic assistance works. That was necessary, it was expensive, and the benefit of it does not belong exclusively to Intuitive.

Who benefits from twenty-seven years of teachingFluency in the console paradigmGeneral, and portablePeer-reviewed outcome evidencePublic, and citable by rivalsIntuitive's own words on new entrantsCompetition validates the categorySystems that fluency currently runs on11,710Intuitive states that the emergence of competition validates robotic-assisted surgery.
The category was proved at Intuitive's expense and the proof is now a public good. What stays proprietary is the interface, which is the smaller part.

The company puts the paradox in its own words: "we believe that the entrance or emergence of competition validates MIS and robotic-assisted surgery or robotic-assisted bronchoscopy"1. Validation cuts in the direction of the category, not the incumbent. A surgeon who understands the console paradigm, tremor filtration, motion scaling and wristed instruments has acquired a general competence; the specific interface is the smaller part of it.

The most valuable teaching Intuitive did was of clinical evidence, and that is a public good. Peer-reviewed outcome studies establishing that robotic prostatectomy or robotic hernia repair produces better results are studies a competitor can cite. The 10-K's own framing — that success depends on "educating hospitals, surgeons, and patients on the demonstrated results associated with robotic-assisted medical procedures"2 — describes work that, once done, does not need doing again.

What remains proprietary is the specific interface fluency, the training record, and the relationships. Those are real and they are why displacement takes years rather than quarters.

Grade this on whether Intuitive's installed base keeps growing faster than its rivals' — 11,710 systems at mid-2026, up 12%3 — and, more subtly, whether new programmes still start with a da Vinci. A teaching hospital that begins a robotics programme on somebody else's console is the leading indicator of everything on this page.

References
  1. ReportedThe company puts the paradox in its own words: "we believe that the entrance or emergence of competition validates MIS and robotic-assisted surgery or robotic-assisted bronchoscopy".
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 1 Business: competition, intellectual property and government regulation (the fourteen named competitors, more than 5,600 patents in force and 2,500 pending, Class II devices cleared under section 510(k) on substantial equivalence, special controls, field actions and recalls) — FY2025 · publ. February 3, 2026 · source ↗
  2. ReportedThe 10-K's own framing — that success depends on "educating hospitals, surgeons, and patients on the demonstrated results associated with robotic-assisted medical procedures" — describes work that, once done, does not need doing again.
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 1 Business: competition, intellectual property and government regulation (the fourteen named competitors, more than 5,600 patents in force and 2,500 pending, Class II devices cleared under section 510(k) on substantial equivalence, special controls, field actions and recalls) — FY2025 · publ. February 3, 2026 · source ↗
  3. ReportedThe measure is whether Intuitive's installed base keeps growing faster than its rivals' — 11,710 systems at mid-2026, up 12% — and, more subtly, whether new programmes still start with a da Vinci.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11,710 da Vinci systems up 12%, 468 placements of which 246 were da Vinci 5, the operating-lease share, the distributor acquisitions in Italy, Spain and Portugal, cash and investments of $8.63 billion, and the factors expected to affect future placements) — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
Sources
Generated September 23, 2026